(Q36419950)

English

A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

based on heuristic

inferred from title

carcinoma of unknown primary

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David Cunningham

2

object named as

Cunningham D

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Rigg A

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Gore M

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hill M

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

O'Brien M

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Nicolson M

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Chang J

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Watson M

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Norman A

9

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hill A

10

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Oates J

11

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Moore H

12

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Ross P

13

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

75

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

101-105

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1997.16

0 references

Management of peritoneal carcinomatosis of unknown primary tumor site

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222694

30 September 2017

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222694

30 September 2017

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222694

30 September 2017

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222694

30 September 2017

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222694

30 September 2017

Axillary metastases from unknown primary sites.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222694

28 June 2018

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222694

28 June 2018

Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222694

28 June 2018

Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/9000605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9000605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of cisplatin, 5-fluorouracil and folinic acid in patients with carcinoma of unknown primary origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9000605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of the patient with adenocarcinoma of unknown origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9000605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unknown primary adenocarcinoma: incidence of overinvestigation and natural history

1 reference

https://pubmed.ncbi.nlm.nih.gov/9000605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Unrecognized Extragonadal Germ Cell Cancer Syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/9000605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of squamous cell carcinoma of unknown origin in cervical lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9000605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9000605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peritoneal carcinomatosis of unknown primary site in women. A distinctive subset of adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9000605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of unknown primary: Identification of a treatable subset?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9000605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9000605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1997.16

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36419950&oldid=1630266430"